Press Release: EnBiotix : Polyphor Publishes Invitation to Extraordinary General Meeting and Announces Financial Results for the First Half 2021
Polyphor publishes invitation to Extraordinary General Meeting and announces financial results for the first half 2021- EGM on October 28, 2021 to be held to prepare merger with EnBiotix Inc, with...
Read full article »
EnBiotix is a Massachusetts-based biotechnology firm that develops and commercializes therapies for the treatment of chronic respiratory disorders.
Read more